Angelman syndrome (AS) is a rare genetic disorder characterized by severe intellectual disability, seizures, lack of speech, and ataxia. The gene responsible for AS was identified as Ube3a and it encodes for E6AP, an E3 ubiquitin ligase. Currently, there is very little known about E6AP's mechanism of action in vivo or how the lack of this protein in neurons may contribute to the AS phenotype. Elucidating the mechanistic action of E6AP would enhance our understanding of AS and drive current research into new avenues that could lead to novel therapeutic approaches that target E6AP's various functions. To facilitate the study of AS, we have generated a novel rat model in which we deleted the rat Ube3a gene using CRISPR. The AS rat phenotypically mirrors human AS with loss of Ube3a expression in the brain and deficits in motor coordination as well as learning and memory. This model offers a new avenue for the study of AS. Autism Res 2020, 13: 397-409.
Angelman syndrome (AS) is a rare genetic disorder characterized by severe intellectual disability, seizures, lack of speech, and ataxia. The gene responsible for AS was identified asUbe3a and it encodes for E6AP, an E3 ubiquitin ligase. Currently, there is very little known about E6AP's mechanism of action in vivo or how the lack of this protein in neurons may contribute to the AS phenotype. Elucidating the mechanistic action of E6AP would enhance our understanding of AS and drive current research into new avenues that could lead to novel therapeutic approaches that target E6AP's various functions. To facilitate the study of AS, we have generated a novel rat model in which we deleted the ratUbe3a gene using CRISPR. The ASrat phenotypically mirrors humanAS with loss of Ube3a expression in the brain and deficits in motor coordination as well aslearning and memory. This model offers a new avenue for the study of AS. Autism Res 2020, 13: 397-409.
Authors: Matthew C Judson; Alain C Burette; Courtney L Thaxton; Alaine L Pribisko; Mark D Shen; Ashley M Rumple; Wilmer A Del Cid; Beatriz Paniagua; Martin Styner; Richard J Weinberg; Benjamin D Philpot Journal: J Neurosci Date: 2017-06-29 Impact factor: 6.167
Authors: Y H Jiang; D Armstrong; U Albrecht; C M Atkins; J L Noebels; G Eichele; J D Sweatt; A L Beaudet Journal: Neuron Date: 1998-10 Impact factor: 17.173
Authors: Anna Adhikari; Nycole A Copping; Julie Beegle; David L Cameron; Peter Deng; Henriette O'Geen; David J Segal; Kyle D Fink; Jill L Silverman; Joseph S Anderson Journal: Hum Mol Genet Date: 2021-06-09 Impact factor: 6.150
Authors: Elizabeth L Berg; Stela P Petkova; Heather A Born; Anna Adhikari; Anne E Anderson; Jill L Silverman Journal: Mol Autism Date: 2021-09-15 Impact factor: 7.509
Authors: Shu-Qun Shi; Carrie E Mahoney; Pavel Houdek; Wenling Zhao; Matthew P Anderson; Xinming Zhuo; Arthur Beaudet; Alena Sumova; Thomas E Scammell; Carl Hirschie Johnson Journal: Front Behav Neurosci Date: 2022-03-23 Impact factor: 3.558
Authors: Anna Adhikari; Fiona K B Buchanan; Timothy A Fenton; David L Cameron; Julian A N M Halmai; Nycole A Copping; Kyle D Fink; Jill L Silverman Journal: Hum Mol Genet Date: 2022-09-10 Impact factor: 5.121
Authors: Stela P Petkova; Anna Adhikari; Elizabeth L Berg; Timothy A Fenton; Jessica Duis; Jill L Silverman Journal: Autism Res Date: 2022-03-10 Impact factor: 4.633